Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 09, 2016
CRYO International, an Air Liquide group subsidiary specializing in temperature-controlled1 logistics solutions, has acquired PDP Couriers, a major player in the customized transport of high value- added products for the pharmaceutical and ...
read more
Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant protein AT-100 as a therapeutic candidate against COVID-19.
read more
AIT Bioscience has announced Jeff Goddard, MBA, as the new CEO and member of the AIT Bioscience Board of Directors.
read more
Thursday, September 13, 2012
AIT Bioscience is pleased to announce that Dr.Ron Bowsher, an industry expert in bioanalysis of ligand binding assays, has partnered with the company as a senior research advisor bringing with him an impressive background in biotherapeutic drug ...
read more
AIT Laboratories (AIT) announces the appointment of R. Matthew Neff as President and Chief Executive Officer of the company, effective August 5, 2013. Neff will also remain in his role as Chairman of the Board for the company. Dr. Michael Evans, the...
read more
AIT Laboratories (AIT) has named Kun Ma, MD, Ph.D., MBA to the position of vice president of science and technology. Dr. Ma comes to the company after most recently serving as director of venture analysis at CHV Capital, Inc., and president and CEO ...
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing services agreement with CytoDyn for the supply of the investigational new drug, leronlimab.
read more
Wednesday, January 27, 2021
Ajinomoto Bio-Pharma Services and Humanigen will be expanding their manufacturing agreement for the fill finish supply of lenzilumab.
read more
Ajinomoto Althea announced that Bert Barbosa and Darwin Richardson, MBA, have joined Althea as Vice President of Drug Product Manufacturing and Vice President of Compliance, respectively.
read more
Ajinomoto Althea Inc., a provider of biotherapeutic contract development and manufacturing services, has announced that the United States Patent and Trademark Office has issued US Patent 9,310,379 covering methods to crystallize monoclonal antibodies...
read more
Ajinomoto Althea is appointing Dr. Lori McDonald as Vice President of Compliance at Althea. Althea's contract manufacturing business continues to grow at a rapid rate driven by biotech companies outsourcing aseptic fill and finish parenteral ...
read more
J. David Enloe, Jr., CEO of Ajinomoto Althea was awarded Most Admired CEO in 2017 by the San Diego Business Journal.
read more
Tuesday, January 28, 2014
Ajinomoto Althea, Inc., a leading Contract Manufacturing Organization providing development and manufacturing services for biotechnology and pharmaceutical companies, announced today its new product offering, Corynex®, to produce secreted, soluble, ...
read more
Tuesday, September 19, 2017
Ajinomoto Althea will soon open a GMP production suite in its newly constructed HPP commercial manufacturing facility located in San Diego.
read more
Ajinomoto Althea Inc., a leading provider of biotherapeutic contract development and manufacturing services, today announced that the United States Patent and Trademark Office has issued US Patent 9,310,379 covering methods to crystallize monoclonal ...
read more